Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Zerodha CASE Nifty Midcap 150 ETF · Direct ✕Nippon India Nifty Pharma ETF · Direct ✕

Growth of ₹10,000

Basics

Zerodha CASE Nifty Midcap 150 ETFNippon India Nifty Pharma ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseZerodhaNippon India
NAV₹11.4101₹29.1708
NAV date19 Nov 202619 Nov 2026
History2.4 years5.4 years
Expense ratio0.2%0.2%
StarsNot ratedNot rated
Growth Score——

Returns

Zerodha CASE Nifty Midcap 150 ETFNippon India Nifty Pharma ETF
1 month+5.34%+10.76%
3 months−2.74%+7.79%
6 months+1.73%+14.37%
YTD+2.63%+25.34%
1 year+2.06%+25.28%
3 years (CAGR)—+21.97%
5 years (CAGR)—+16.60%
10 years (CAGR)——
Since launch+4.57%+14.02%

Risk

Zerodha CASE Nifty Midcap 150 ETFNippon India Nifty Pharma ETF
Volatility—15.0%
Downside volatility—9.0%
Sharpe—1.03
Sortino—1.71
Calmar—1.33
Return / risk—1.47
Deepest fall−20.81%−20.98%
Days to recover257136
Below its high−3.75%−1.80%

Against benchmark

Zerodha CASE Nifty Midcap 150 ETFNippon India Nifty Pharma ETF
Alpha—−0.00%
Beta—1.00
R²—100.0%
Up capture—100.0%
Down capture—100.0%
Tracking error—0.0%
Information ratio——
Treynor—0.14

Consistency

Zerodha CASE Nifty Midcap 150 ETFNippon India Nifty Pharma ETF
Best 1-year+22.29%+65.21%
Middle 1-year+6.15%+13.45%
Worst 1-year−5.36%−15.30%
1-year periods with a loss13.4%25.8%
Middle 3-year—+20.51%
Positive months—61.1%
Best day+3.97%+3.64%
Worst day−3.92%−4.03%
Worst 5% day−2.04%−1.62%
Positive days55.2%54.4%
NAVs a year248248

SIP of ₹10,000 a month

Zerodha CASE Nifty Midcap 150 ETFNippon India Nifty Pharma ETF
5-year XIRR—+20.60%
5-year value—₹10,11,201
3-year XIRR—+19.58%
1-year XIRR+5.72%+34.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth